world cancer report - iarc
world cancer report - iarc
world cancer report - iarc
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Partial cystectomy is appropriate for only a<br />
minor proportion of patients with invasive<br />
bladder <strong>cancer</strong>. Radical radiation therapy<br />
as sole treatment has been evaluated, and<br />
criteria contributing to a favourable outcome<br />
(tumour size, stage, morphology,<br />
REFERENCES<br />
1. Ferlay J, Bray F, Parkin DM, Pisani P, eds (2001)<br />
Globocan 2000: Cancer Incidence and Mortality Worldwide<br />
(IARC Cancer Bases No. 5), Lyon, IARCPress.<br />
2. Brennan P, Bogillot O, Cordier S, Greiser E, Schill W,<br />
Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-<br />
Audorff U, Jockel KH, Donato F, Serra C, Wahrendorf J,<br />
Hours M, T'Mannetje A, Kogevinas M, Boffetta P (2000)<br />
Cigarette smoking and bladder <strong>cancer</strong> in men: a pooled<br />
analysis of 11 case-control studies. Int J Cancer, 86: 289-<br />
294.<br />
3. Silverman DT, Morrison AS, Devesa SS (1996) Bladder<br />
<strong>cancer</strong>. In: Scottenfeld D, Fraumeni, FJ eds, Cancer<br />
Epidemiology and Prevention, Oxford, New York, Oxford<br />
University Press, 1156-1179.<br />
4. Pisani P, Parkin DM, Muñoz N, Ferlay J (1997) Cancer<br />
and infection: estimates of the attributable fraction in<br />
1990. Cancer Epidemiol Biomarkers Prev, 6: 387-400.<br />
5. Saad A, Hanbury DC, McNicholas TA, Boustead GB,<br />
Woodman AC (2001) The early detection and diagnosis of<br />
bladder <strong>cancer</strong>: a critical review of the options. Eur Urol,<br />
39: 619-633.<br />
6. Lee R, Droller MJ (2000) The natural history of bladder<br />
<strong>cancer</strong>. Implications for therapy. Urol Clin North Am, 27: 1-<br />
13, vii.<br />
etc.) have been determined. Tumour staging<br />
is based on the degree to which the<br />
tumour has invaded the bladder wall.<br />
In more developed countries, five-year relative<br />
survival is in the order of 65% (Fig.<br />
5.87), and there has been a steady<br />
7. Noss M, Klotz L (1998) Male urogenital <strong>cancer</strong>. In:<br />
Morris D, Kearsley J, Williams C eds, Cancer: a comprehensive<br />
clinical guide, Harwood Academic Publishers, 213-<br />
222.<br />
8. d'Errico A, Malats N, Vineis P, Boffetta P (1999) Review<br />
of studies of selected metabolic polymorphisms and <strong>cancer</strong>.<br />
In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N,<br />
Cuzick J, Boffetta P eds, Metabolic Polymorphisms and<br />
Susceptibility to Cancer (IARC Scientific Publication No.<br />
148), Lyon, IARCPress, 323-393.<br />
9. Brandau S, Bohle A (2001) Bladder <strong>cancer</strong>. I. Molecular<br />
and genetic basis of carcinogenesis. Eur Urol, 39: 491-497.<br />
10. Metts MC, Metts JC, Milito SJ, Thomas CR, Jr. (2000)<br />
Bladder <strong>cancer</strong>: a review of diagnosis and management. J<br />
Natl Med Assoc, 92: 285-294.<br />
11. Maluf FC, Bajorin DF (2001) Chemotherapy agents in<br />
transitional cell carcinoma: the old and the new. Semin<br />
Urol Oncol, 19: 2-8.<br />
improvement during the last decades.<br />
Survival is poorer in developing countries,<br />
with five-year relative survival rates of 30-<br />
50%.<br />
WEBSITE<br />
NCI Bladder Cancer Homepage.<br />
http://www.<strong>cancer</strong>.gov/<strong>cancer</strong>_information/<strong>cancer</strong>_type/<br />
bladder/<br />
Bladder <strong>cancer</strong><br />
231